Evidence map›Paper›PMID 2212010›Full record

ArticleThe Journal of clinical investigation1990

Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes.

G D Demetri, T J Ernst, E S Pratt, B W Zenzie, J G Rheinwald, J D Griffin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

G D DemetriDivision of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts.
T J Ernst
E S Pratt
B W Zenzie
J G Rheinwald
J D Griffin
Dana-Farber Cancer Institute · USHarvard University · US

Funding

SURFACE ANTIGENS OF MYELOID PROGENITOR CELLSR01CA036167 · NCI · DANA-FARBER CANCER INSTITUTE · PI GRIFFIN, JAMES DOUGLAS · 1985 to 2007
$1.8M
REGULATION OF MYELOPOIESISR37CA036167 · NCI · DANA-FARBER CANCER INSTITUTE · PI GRIFFIN, JAMES D · 1995 to 2002
$863k
THE BIOLOGY AND TREATMENT OF HUMAN LEUKEMIA AND LYMPHOMAP01CA034183 · NCI · DANA-FARBER CANCER INSTITUTE · PI SCHLOSSMAN, STUART F · 1985 to 1994
–
REGULATION OF CSF PRODUCTION BY NORMAL HUMAN CELLSR01CA047843 · NCI · DANA-FARBER CANCER INSTITUTE · PI GRIFFIN, JAMES D · 1988 to 1990
–
NCI NIH HHS CA-34183NCI NIH HHS CA-36167NCI NIH HHS CA-47843
6 · The paper itself

Abstract

Autonomous production of cytokines such as the hematopoietic colony-stimulating factors (CSFs), IL-1, or IL-6 has been demonstrated in numerous human and murine neoplasms, and may be involved in the pathogenesis of several paraneoplastic syndromes such as leukocytosis, fever, and hypercalcemia. Because of the high frequency with which mutations in ras protooncogenes have been detected in human tumors, as well as evidence linking ras gene products to activation of certain cellular functions, we investigated whether ras mutations might influence the regulation of cytokine genes. Normal human fibroblasts transfected with a mutant val12 H-ras oncogene expressed increased levels of mRNA transcripts encoding granulocyte-CSF (G-CSF), granulocyte-macrophage-CSF (GM-CSF), and IL-1 beta compared with controls. Human mesothelioma cells transfected with a mutant asp12 N-ras oncogene exhibited similar alterations in cytokine gene expression. Estimates of transcriptional activity by nuclear run-on analysis revealed a selective increase in transcription only for the IL-1 gene. Analysis of mRNA half-life demonstrated a marked increase in the stability of numerous cytokine transcripts, including G-CSF, GM-CSF, IL-1, and IL-6. The addition of anti-IL-1 neutralizing antibody to cultures of cells expressing ras mutants did not block the expression of any of the cytokines examined, suggesting that the baseline expression of GM-CSF, G-CSF, and IL-6 was not a secondary event due to the increased transcription of IL-1. These results indicate that mutations in ras genes may alter expression of several cytokine genes through both transcriptional and posttranscriptional mechanisms.

Indexed as

Gene Expression RegulationGenes, rasTranscription, GeneticCells, CulturedColony-Stimulating FactorsCytokinesHumansInterleukin-1Interleukin-6MutationRepetitive Sequences, Nucleic AcidRNA, MessengerColony-Stimulating FactorsCytokinesInterleukin-1Interleukin-6RNA, Messenger

Identifiers

PMID2212010
PMCPMC296857
OpenAlexW2011643484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.